关注
Esmaeil Mehrara
Esmaeil Mehrara
Medical Physicist
在 gu.se 的电子邮件经过验证
标题
引用次数
引用次数
年份
Specific growth rate versus doubling time for quantitative characterization of tumor growth rate
E Mehrara, E Forssell-Aronsson, H Ahlman, P Bernhardt
Cancer research 67 (8), 3970-3975, 2007
2642007
Quantitative analysis of tumor growth rate and changes in tumor marker level: specific growth rate versus doubling time
E Mehrara, E Forssell-Aronsson, H Ahlman, P Bernhardt
Acta Oncologica 48 (4), 591-597, 2009
512009
Objective assessment of tumour response to therapy based on tumour growth kinetics
E Mehrara, E Forssell-Aronsson, P Bernhardt
British journal of cancer 105 (5), 682-686, 2011
322011
A new method to estimate parameters of the growth model for metastatic tumours
E Mehrara, E Forssell-Aronsson, V Johanson, L Kölby, R Hultborn, ...
Theoretical Biology and Medical Modelling 10, 1-12, 2013
182013
Analysis of inter-patient variations in tumour growth rate
E Mehrara, E Forssell-Aronsson
Theoretical Biology and Medical Modelling 11, 1-11, 2014
112014
Quantitative analysis of tumor growth and response to therapy
E Mehrara
Department of Physics; Institutionen för fysik, 2010
32010
Estimation of tumour volume at therapy initiation by back-extrapolating the post-therapy regression curve of tumour volume
E Mehrara, E Forssell-Aronsson
Applied Cancer Research 38, 1-5, 2018
12018
Thermoluminescence dosimetry (TLD) in a 3 T magnetic resonance imaging (MRI) environment: implications for personnel exposure monitoring
E Mehrara
Biomedical Physics & Engineering Express 10 (4), 045020, 2024
2024
Cardiac motion artifacts from patient breathing in myocardial perfusion imaging, importance of breathing method.
J Khan, Z Alhashemi, G Harmansson, E Mehrara
EANM'18, 2018
2018
[OA105] Is CZT-spect dedicted system for myocardial imaging reliable in assessment of left ventricular voulmes as compared to echocardiography?
J Khan, J Dalmo, J Himmelman, E Mehrara, Y Suràc, G Hermansson, ...
Physica Medica: European Journal of Medical Physics 52, 41, 2018
2018
Modeling of treatment effects of 177Lu-DOTATATE on human carcinoid tumor GOT1 in a mouse model
E Mehrara, P Bernhardt, H Ahlman, E Forssell-Aronsson
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 39, S325-S325, 2012
2012
Simulation of metastatic distributions and metastatic cure probability after radionuclide therapy
P Bernhardt, J Svensson, J Kindblom, E Mehrara, M Rizell, T Speer
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 39, S318-S318, 2012
2012
Assessment of tumour response to therapy
E Mehrara, E Forssell-Aronsson, P Bernhardt
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 38, S427-S427, 2011
2011
ESTIMATION OF TUMOUR GROWTH MODEL, TUMOUR FORMATION TIME, AND METASTASIS FORMATION RATE IN CLINICAL SETTINGS
E Mehrara, E Forssell-Aronsson, V Johanson, L Kolby, H Ahlman, ...
RADIOTHERAPY AND ONCOLOGY 88, S468-S468, 2008
2008
Quantitative Analysis of Tumor Growth and Dissemination
E Mehrara
Department of Radiation Physics, Göteborg University, 2007
2007
Estimation of cure after somatostatin-receptor based radionuclide therapy in patients with disseminated midgut carcinoids in the liver
P Bernhardt, E Mehrara, L Kolby, H Ahlman, EF Aronsson
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 33, S325-S326, 2006
2006
系统目前无法执行此操作,请稍后再试。
文章 1–16